HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer still lacking effective treatment options. Chemotherapy in combination with immunotherapy can restrict tumor progression and repolarize the tumor microenvironment towards an anti-tumor milieu, improving clin...
Збережено в:
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2024-03-01
|
| Серія: | Frontiers in Chemistry |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fchem.2024.1378233/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|